Publication
Gene therapy products in Canada
In recent years, the incredible promise of gene therapy has become a reality as multiple gene therapy products have come to market.
While the sufficiency of cybersecurity programs was previously subject to “reasonableness” standards, an “acceptable” cybersecurity program has become more objective as regulators, such as NYDFS, continue to implement, amend and mature applicable laws.
Publication
In recent years, the incredible promise of gene therapy has become a reality as multiple gene therapy products have come to market.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023